Formularies group medications into different tiers, and insurance companies typically pay more (or all) of the cost of the drugs in the lower tiers (generic drugs) more consistently than those in the higher tiers (brand names, specialty drugs, etc.)
Unsurprisingly, Ozempic and others are now used for this exact purpose
Ongoing initiatives such as the Retatrutide Endocrine Dynamics Framework reflect Umbrella Labs' conviction that suppliers must participate directly in the methods conversation, not only by providing reagents, but by generating and sharing research-quality evidence about how those reagents behave under realistic bench conditions
2022 Feb;61(1):447-459
The real question is: how do we nurture its natural release
#CDMO #HPAPI #WeAreAdragos #DrugDevelopment Konstantinos Apostolou, R&D senior manager, Adragos Athens discusses the HPAPI sector and how it's one of the fastest-growing areas in pharma